177 related articles for article (PubMed ID: 24131750)
1. Medulloblastoma with multi-lineage differentiation including myogenic and melanotic elements: a case report with molecular data.
Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C
Clin Neuropathol; 2014; 33(2):122-7. PubMed ID: 24131750
[TBL] [Abstract][Full Text] [Related]
2. Myogenic and melanotic differentiated medulloblastoma: case report.
Borcek AO; Durdag E; Emmez H; Kurt G; Baykaner MK
Turk Neurosurg; 2011; 21(3):438-42. PubMed ID: 21845588
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma occurring at the site of a previous medulloblastoma following a 5-year remission period.
Martin SE; Brat DJ; Vance GH; Stohler R; Choi H; Douglas-Akinwande AC; Hattab EM
Neuropathology; 2012 Oct; 32(5):543-50. PubMed ID: 22151431
[TBL] [Abstract][Full Text] [Related]
4. [Melanotic medulloblastoma. Ultrastructural and histochemical study of a case].
García-Bragado F; Cabello A; Guarch R; Ruiz de Azúa Y; Ezpeleta I
Arch Neurobiol (Madr); 1990; 53(1):8-12. PubMed ID: 2203326
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma with focal divergent/teratoid differentiation.
Majumdar K; Tyagi I; Saran RK; Sakhuja P; Sharma A
Brain Tumor Pathol; 2013 Jan; 30(1):50-6. PubMed ID: 22615000
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
7. Large cell/anaplastic medulloblastoma with myogenic, melanotic and neuronal differentiation: a case report of a rare tumor.
Fathaddin AA; Bakhash EA; Sabbagh AJ; Al-Dandan SW
Indian J Pathol Microbiol; 2014; 57(2):294-7. PubMed ID: 24943770
[TBL] [Abstract][Full Text] [Related]
8. Melanocytic medulloblastoma with ganglioneurocytomatous differentiation: a case report.
Kubota KC; Itoh T; Yamada Y; Yamaguchi S; Ishida Y; Nakasu Y; Watanabe R; Ito I; Sawamura Y; Matsuno Y; Nagashima K
Neuropathology; 2009 Feb; 29(1):72-7. PubMed ID: 18422908
[TBL] [Abstract][Full Text] [Related]
9. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
Ellison DW; Kocak M; Dalton J; Megahed H; Lusher ME; Ryan SL; Zhao W; Nicholson SL; Taylor RE; Bailey S; Clifford SC
J Clin Oncol; 2011 Apr; 29(11):1400-7. PubMed ID: 20921458
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma with myogenic differentiation showing double immunopositivity for synaptophysin and myoglobin.
Kido M; Ueno M; Onodera M; Matsumoto K; Imai T; Haba R; Tamiya T; Huang CL; Sakamoto H
Pathol Int; 2009 Apr; 59(4):255-60. PubMed ID: 19351370
[TBL] [Abstract][Full Text] [Related]
11. "Primary" leptomeningeal medulloblastoma.
Mehta RI; Cutler AR; Lasky JL; Yong WH; Lerner JT; Hirota BK; Salamon N; Mathern GW; Vinters HV
Hum Pathol; 2009 Nov; 40(11):1661-5. PubMed ID: 19695677
[TBL] [Abstract][Full Text] [Related]
12. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
[TBL] [Abstract][Full Text] [Related]
13. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
[TBL] [Abstract][Full Text] [Related]
14. Medullomyoblastoma: a case report and literature review of a rare tumor entity.
Smolle E; Al-Qubati S; Stefanits H; Haberler C; Kleinert R; Haybaeck J
Anticancer Res; 2012 Nov; 32(11):4939-44. PubMed ID: 23155263
[TBL] [Abstract][Full Text] [Related]
15. Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis.
Polydorides AD; Perry A; Edgar MA
J Neurooncol; 2008 Jun; 88(2):193-7. PubMed ID: 18317693
[TBL] [Abstract][Full Text] [Related]
16. Large-cell medulloblastoma with arrestin-like protein expression.
Vincent S; Mirshari M; Nicolas C; Adenis C; Dhellemmes P; Soto Ares G; Maurage CA; Baranzelli MC; Giangaspero F; Ruchoux MM
Clin Neuropathol; 2003; 22(1):1-9. PubMed ID: 12617187
[TBL] [Abstract][Full Text] [Related]
17. Isolated Bone Recurrence of Medulloblastoma With MYCN Amplification and TP53 Loss: A Case Report.
Takahashi Y; Kudo K; Ogawa K; Sato T; Kamio T; Sasaki S; Kobayashi A; Ito T; Yamamoto T; Asano K; Ohkuma H; Kurose A; Ito E; Terui K
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e593-e596. PubMed ID: 34133388
[TBL] [Abstract][Full Text] [Related]
18. Stratification of medulloblastoma on the basis of histopathological grading.
Giangaspero F; Wellek S; Masuoka J; Gessi M; Kleihues P; Ohgaki H
Acta Neuropathol; 2006 Jul; 112(1):5-12. PubMed ID: 16685513
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma with myogenic and/or melanotic differentiation does not align immunohistochemically with the genetically defined molecular subgroups.
Gupta K; Jogunoori S; Satapathy A; Salunke P; Kumar N; Radotra BD; Vasishta RK
Hum Pathol; 2018 May; 75():26-33. PubMed ID: 29412177
[TBL] [Abstract][Full Text] [Related]
20. Cerebellar medullomyoblastoma with melanotic tubular structures.
Nozza P; Milanaccio C; Piatelli G; Rossi A; Raso A; Cama A; Garré ML; Pietsch T
Pediatr Blood Cancer; 2008 Jan; 50(1):183-5. PubMed ID: 16550533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
